SCHEMBL693223

SCHEMBL693223

C[C@H](Cc1cccc(CCNC(=O)OC(C)(C)C)c1)NCCc1ccccc1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIGMAR1 Q99720 6/20 0.53
SLC2A1 P11166 4/20 0.48
CTSK P43235 2/20 0.47
CTSB P07858 1/20 0.47
CTSS P25774 1/20 0.47
CYP3A4 P08684 3/20 0.46
CYP1A2 P05177 2/20 0.46
CYP2D6 P10635 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
CYP2C19 P33261 1/20 0.46
USP2 O75604 2/20 0.46
NR1I2 O75469 1/20 0.46
ADRB1 P08588 1/20 0.46
HTR1A P08908 1/20 0.46
ADRA2A P08913 1/20 0.46
ADORA3 P0DMS8 1/20 0.46
ADRA2B P18089 1/20 0.46
ADRA2C P18825 1/20 0.46
CHRM3 P20309 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3933847 0.87 CA2 (0.48) CTSKCTSBCTSSNAMPTIDO1
SCHEMBL730856 0.86 SIGMAR1 (0.50) SIGMAR1CTSKCTSBCTSSCYP3A4
SCHEMBL730857 0.86 SIGMAR1 (0.50) SIGMAR1CTSKCTSBCTSSCYP3A4
SCHEMBL14977016 0.86 SIGMAR1 (0.50) SIGMAR1CTSKCTSBCTSSCYP3A4
SCHEMBL731698 0.84 CA2 (0.51) CTSKCTSBCTSSNAMPTIDO1
SCHEMBL6414451 0.84 CA2 (0.51) CTSKCTSBCTSSNAMPTIDO1
SCHEMBL731697 0.84 CA2 (0.51) CTSKCTSBCTSSNAMPTIDO1
SCHEMBL572740 0.83 IDO1 (0.60) SIGMAR1CTSKCTSSCYP3A4CYP1A2
SCHEMBL693222 0.80 CTSK (0.44) SIGMAR1CTSKCTSBCTSSNAMPT
SCHEMBL16798316 0.79 NQO2 (0.50) SIGMAR1CTSKCYP3A4NAMPTIDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2421849-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND BETA2 ADRENERGIC RECEPTOR AGONIST ACTIVITY Theravance, Inc. (US) 2012-02-29 EP disclosed
WO-2010123766-A1 DIAMIDE COMPOUNDS HAVING MUSCARINIC RECEPTOR ANTAGONIST AND β2 ADRENERGIC RECEPTOR AGONIST ACTIVITY THERAVANCE, INC. (US) 2010-10-28 WO disclosed